The Norwegian Biotechnology Advisory Board apply for financial support to arrange a state-of-the-art vaccine conference addressing the risks and benefits of new genetic vaccines, the need for these vaccines in developing countries and the regulatory chall enges Norwegian legislation puts on Norwegian researchers participating in collaborations to develop these vaccines.